The U.S. Court of Appeals for the Federal Circuit has upheld a decision by the Patent Trial and Appeal Board (PTAB) to invalidate claims in two patents held by Sage Products LLC, a unit of Stryker Corporation. These patents were related to sterilizing antiseptics. As reported on Law360, the appeals court’s decision confirms the PTAB’s earlier conclusion regarding the invalidation of these claims. This ruling marks a significant moment in the ongoing assessment of patent claims within the medical sterilization sector, underscoring the stringent evaluations being conducted by the relevant legal bodies to ensure adherence to patent laws and standards.